SCHEMBL14720484

SCHEMBL14720484

CCOC(=O)c1ccc(C(C)=C2CCN(C3CCC3)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
POLB P06746 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.47
MAPK1 P28482 1/20 0.46
FDFT1 P37268 1/20 0.45
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
HTT P42858 2/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 5/20 0.43
NPC1 O15118 3/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
ESR1 P03372 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
ESR2 Q92731 1/20 0.43
CA14 Q9ULX7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720551 0.81 ALDH1A1 (0.56) ALDH1A1POLBSMN1; SMN2MAPK1FDFT1
SCHEMBL2819437 0.80 HRH3 (0.56) ALDH1A1POLBMAPK1
SCHEMBL63892 0.80 ALDH1A1 (0.63) ALDH1A1POLBSMN1; SMN2MAPK1FDFT1
SCHEMBL14720485 0.79 ALDH1A1 (0.54) ALDH1A1POLBSMN1; SMN2MAPK1FDFT1
SCHEMBL14720724 0.78 ALDH1A1 (0.58) ALDH1A1POLBSMN1; SMN2MAPK1FDFT1
SCHEMBL14720722 0.78 KDM2B (0.43) OPRM1OPRD1OPRK1
SCHEMBL6135228 0.77 ALDH1A1 (0.67) ALDH1A1POLBSMN1; SMN2MAPK1FDFT1
SCHEMBL6134915 0.76 ALDH1A1 (0.65) ALDH1A1POLBSMN1; SMN2MAPK1HTT
SCHEMBL4126209 0.75 ALDH1A1 (0.55) ALDH1A1POLBSMN1; SMN2HTTHPGD
SCHEMBL14723520 0.74 ATM (0.50) ALDH1A1SMN1; SMN2RAB9ANPC1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed